Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16789
Title: Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia
Austin Authors: Dowman, Leona M ;McDonald, Christine F ;Bozinovski, Steven;Vlahos, Ross;Gillies, Rebecca;Pouniotis, Dodie S;Hill, Catherine J ;Goh, Nicole S L ;Holland, Anne E 
Affiliation: Department of Respiratory & Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
Department of Physiotherapy, Austin Health, Heidelberg, Victoria, Australia
Discipline of Physiotherapy, La Trobe University, Alfred Centre, Melbourne, Victoria, Australia
Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia
School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia
Department of Physiotherapy, Alfred Health, Melbourne, Victoria, Australia
Issue Date: Jul-2017
metadata.dc.date: 2017-02-22
Publication information: Respirology 2017; 22(5): 957-964
Abstract: BACKGROUND AND OBJECTIVE: Supplemental oxygen is commonly prescribed in patients with idiopathic pulmonary fibrosis (IPF), although its benefits have not been proven. The aims of this study were to investigate the effect of oxygen on oxidative stress, cytokine production, skeletal muscle metabolism and physiological response to exercise in IPF. METHODS: Eleven participants with IPF received either oxygen, at an FiO2 of 0.50, or compressed air for 1 h at rest and during a cycle endurance test at 85% of peak work rate. Blood samples collected at rest and during exercise were analysed for markers of oxidative stress, skeletal muscle metabolism and cytokines. The protocol was repeated a week later with the alternate intervention. RESULTS: Compared with air, oxygen did not adversely affect biomarker concentrations at rest and significantly improved endurance time (mean difference = 99 ± 81s, P = 0.002), dyspnoea (-1 ± 1 U, P = 0.02), systolic blood pressure (BP; -11 ± 11 mm Hg, P = 0.006), nadir oxyhaemoglobin saturation (SpO2 ; 8 ± 6%, P = 0.001), SpO2 at 2-min (7 ± 6%, P = 0.003) and 5-min isotimes (5 ± 3, P < 0.001) and peak exercise xanthine concentrations (-42 ± 73 µmol/L, P = 0.03). Air significantly increased IL-10 (5 ± 5 pg/mL, P = 0.04) at 2-min isotime. Thiobarbituric acid-reactive substances (TBARs), IL-6, TNF-α, creatine kinase, lactate, heart rate and fatigue did not differ between the two interventions at any time point. CONCLUSION: In patients with IPF, breathing oxygen at FiO2 of 0.50 at rest seems safe. During exercise, oxygen improves exercise tolerance, alleviates exercise-induced hypoxaemia and reduces dyspnoea. A potential relationship between oxygen administration and improved skeletal muscle metabolism should be explored in future studies.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16789
DOI: 10.1111/resp.13002
ORCID: 0000-0001-6481-3391
0000-0003-2061-845X
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/28225205
Type: Journal Article
Subjects: Exercise
Idiopathic pulmonary fibrosis
Metabolism
Oxidative stress
Oxygen
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Jun 19, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.